Las Vegas, NV -- (SBWIRE) -- 01/17/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Rite Aid Corporation(NYSE:RAD), DryShips Inc.(NASDAQ:DRYS), Chelsea Therapeutics International Ltd.(NASDAQ:CHTP), Chimera Investment Corporation (NYSE:CIM)
Rite Aid Corporation(NYSE:RAD) was a volume gainer of 22.65 million shares and the average volume of the stock remained 30.73 million shares. The stock opened the session at $5.50 and finished at the end of the day at $5.59 and the stock escalated 1.64%.The market capitalization of the stock remained 5.40 billion. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
For How Long RAD will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, DryShips Inc.(NASDAQ:DRYS) exchanged 20.82 million shares and the average volume remained 17.75 million shares. The stock closed the session at $3.99 with the drop of -0.25%. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. DryShips Inc. owns a fleet of 42 drybulk carriers comprising 12 Capesize, 28 Panamax, and 2 Supramax with a combined deadweight tonnage of approximately 4.4 million tons; and 10 tankers comprising 4 Suezmax and 6 Aframax with a combined deadweight tonnage of approximately 1.3 million tons.
Why Should Investors Buy DRYS After the Recent Fall? Just Go Here and Find Out
Chelsea Therapeutics International Ltd.(NASDAQ:CHTP) enhanced 6.58% and its closing price was $4.70. The volume of the stock was 16.93 million shares and the average volume remained 4.48 million shares. The market capitalization of the stock remained 368.64 million. The beta of the stock remained 1.36. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.
Why Should Investors Buy CHTP After The Recent Gain? Just Go Here and Find Out
Chimera Investment Corporation (NYSE:CIM) exchanged 13.35 million shares in the previous trading session, and its average trading remained 9.85 million shares. CIM advanced 0.33% and it closed the trading at $3.04. The market capitalization of the stock remained 3.12 billion. Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes.
For How Long CIM’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)